Hyaluronidase 51662-1555-01
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 4, 2021
- Listing Expires
- December 31, 2026
- Application
- BLA021859
Need to source Hyaluronidase? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hyaluronidase (human Recombinant) | 150 [USP'U]/mL |
Drug Class
Endoglycosidase [EPC]Endoglycosidase [EPC]Glycoside Hydrolases [CS]
Selected Package
51662-1555-01Selected1 VIAL in 1 BOX (51662-1555-1) / 1 mL in 1 VIAL